Journal Article Summary
The article investigates the relationship between chronic antihistamine use and the incidence of long COVID and thrombotic events in patients who have contracted COVID-19. This topic is significant because long COVID and increased thrombosis rates have emerged as concerning complications following COVID-19 infections, particularly in older adults. Understanding whether antihistamines can mitigate these risks could inform treatment strategies and improve patient outcomes.
The researchers analyzed data from over 192,000 patients in the metropolitan area of Barcelona, focusing on those with chronic antihistamine prescriptions. They found that patients taking antihistamines did not report any cases of long COVID, even after multiple infections, while the prevalence of long COVID increased in those not using antihistamines. Additionally, thrombotic events were significantly less frequent among antihistamine users, suggesting a potential protective effect against these complications.
However, the study has limitations, including the possibility that it may underestimate the true incidence of thrombotic events by excluding patients who died early from such complications. The findings are based on observational data, which means they cannot definitively establish causation. Patients should discuss these findings with their healthcare professionals, especially if they are considering antihistamines for managing COVID-19 symptoms or if they have concerns about long COVID and thrombosis.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Puigdellívol-Sánchez Anna, Arévalo-Genicio Antonio, García-Arqué Mª Carmen, Gragea-Nocete Marta, Lozano-Paz Celia, Moro-Casasola Vanessa, Pérez-Díaz Cristina, Valls-Foix Roger, et al.. Long COVID and Reduced Thrombosis in Antihistamine-Treated Patients: An Observational Study in the Metropolitan Area of Barcelona. Viruses 2026. DOI: 10.3390/v18020197. PMID: 41754542. PMCID: PMC12945107.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
